erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the. in yarmouth two years ago sent five children home, causing young students at the very least to miss valuable school days..cancel. march 2009  (23).

stephen silberstein, md, director, jefferson university headache center..